Authors:
Foncuberta, MC
Cagnoni, PJ
Brandts, CH
Mandanas, R
Fields, K
Derigs, HG
Reed, E
Sonis, ST
Fay, J
LeVeque, F
Pouillart, P
Schrezenmeier, H
Emmons, R
Thiel, E
Citation: Mc. Foncuberta et al., Topical transforming growth factor-beta 3 in the prevention or alleviationof chemotherapy-induced oral mucositis in patients with lymphomas or solidtumors, J IMMUNOTH, 24(4), 2001, pp. 384-388
Authors:
Nieto, Y
Champlin, RE
Wingard, JR
Vredenburgh, JJ
Elias, AD
Richardson, PR
Glaspy, J
Jones, RB
Stiff, PJ
Bearman, SI
Cagnoni, PJ
McSweeney, PA
LeMaistre, CF
Pecora, AL
Shpall, EJ
Citation: Y. Nieto et al., Status of high-dose chemotherapy for breast cancer: A review, BIOL BLOOD, 6(5), 2000, pp. 476-495
Authors:
Nieto, Y
Cagnoni, PJ
Bearman, SI
Shpall, EJ
Matthes, S
Jones, RB
Citation: Y. Nieto et al., Cardiac toxicity following high-dose cyclophosphamide, cisplatin, and BCNU(STAMP-I) for breast cancer, BIOL BLOOD, 6(2A), 2000, pp. 198-203
Authors:
Cagnoni, PJ
Walsh, TJ
Prendergast, MM
Bodensteiner, D
Hiemenz, S
Greenberg, RN
Arndt, CAS
Schuster, M
Seibel, N
Yeldandi, V
Tong, KB
Citation: Pj. Cagnoni et al., Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients, J CL ONCOL, 18(12), 2000, pp. 2476-2483
Authors:
Nieto, Y
Cagnoni, PJ
Nawaz, S
Shpall, EJ
Yerushalmi, R
Cook, B
Russell, P
McDermit, J
Murphy, J
Bearman, SI
Jones, RB
Citation: Y. Nieto et al., Evaluation of the predictive value of Her-2/neu overexpression and p53 mutations in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplantation, J CL ONCOL, 18(10), 2000, pp. 2070-2080
Authors:
Nieto, Y
Russ, P
Everson, G
Bearman, SI
Cagnoni, PJ
Jones, RB
Shpall, EJ
Citation: Y. Nieto et al., Acute pancreatitis during immunosuppression with tacrolimus following an allogeneic umbilical cord blood transplantation, BONE MAR TR, 26(1), 2000, pp. 109-111
Authors:
Nieto, Y
Cagnoni, PJ
Shpall, EJ
Matthes, S
Baron, A
Jones, RB
Bearman, SI
Citation: Y. Nieto et al., Phase II trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic disease, CLIN CANC R, 5(7), 1999, pp. 1731-1737
Authors:
Nieto, Y
Xu, XH
Cagnoni, PJ
Matthes, S
Shpall, EJ
Bearman, SI
Murphy, J
Jones, RB
Citation: Y. Nieto et al., Nonpredictable pharmacokinetic behavior of high-dose cyclophosphamide in combination with cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea, CLIN CANC R, 5(4), 1999, pp. 747-751
Authors:
Nieto, Y
Cagnoni, PJ
Shpall, EJ
Xu, XS
Murphy, J
Vredenburgh, J
Chao, NJ
Bearman, SI
Jones, RB
Citation: Y. Nieto et al., A predictive model for relapse in high-risk primary breast cancer patientstreated with high-dose chemotherapy and autologous stem-cell transplant, CLIN CANC R, 5(11), 1999, pp. 3425-3431
Authors:
Johnson, DW
Cagnoni, PJ
Schossau, TM
Stemmer, SM
Grayeb, DEM
Baron, AE
Shpall, EJ
Bearman, SI
McDermitt, J
Jones, RB
Citation: Dw. Johnson et al., Optic disc and retinal microvasculopathy after high-dose chemotherapy and autologous hematopoietic progenitor cell support, BONE MAR TR, 24(7), 1999, pp. 785-792
Authors:
Bearman, SI
Vredenburh, JJ
Cagnoni, PJ
Shpall, EJ
Nieto, Y
Ross, M
Peters, WP
Jones, RB
Citation: Si. Bearman et al., High-dose therapy with autologous hematopoietic cell support as salvage treatment for patients with breast cancer who have relapsed after previous high-dose chemotherapy, BONE MAR TR, 24(5), 1999, pp. 491-495
Authors:
Cagnoni, PJ
Matthes, S
Day, TC
Bearman, SI
Shpall, EJ
Jones, RB
Citation: Pj. Cagnoni et al., Modification of the pharmacokinetics of high-dose cyclophosphamide and cisplatin by antiemetics, BONE MAR TR, 24(1), 1999, pp. 1-4
Authors:
Nieto, Y
Ross, M
Gianani, R
Shpall, EJ
Cagnoni, PJ
Bearman, SI
Jones, RB
Citation: Y. Nieto et al., Post-mortem incidental finding of cytomegalovirus oophoritis after an allogeneic stem cell transplant, BONE MAR TR, 23(12), 1999, pp. 1323-1324